{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:41:41Z","timestamp":1789087301577,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071416"],"award-info":[{"award-number":["82071416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101326"],"award-info":[{"award-number":["82101326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Municipal University (Faculty) Joint Funding Project","award":["2023A03J01331"],"award-info":[{"award-number":["2023A03J01331"]}]},{"name":"Municipal University (Faculty) Joint Funding Project","award":["2023A03J01363"],"award-info":[{"award-number":["2023A03J01363"]}]},{"name":"Central Government Guiding Local Science and Technology Development Projects","award":["ZYYD2022C17"],"award-info":[{"award-number":["ZYYD2022C17"]}]},{"DOI":"10.13039\/501100013068","name":"Key Technologies Research and Development Program of Guangzhou Municipality","doi-asserted-by":"publisher","award":["2023B03J0631"],"award-info":[{"award-number":["2023B03J0631"]}],"id":[{"id":"10.13039\/501100013068","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1515230004"],"award-info":[{"award-number":["2022B1515230004"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12035-025-05153-4","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T02:27:05Z","timestamp":1750300025000},"page":"13500-13512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Upregulation of PD-1 on Peripheral T cells Subsets is Associated with Parkinson's Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Zhi-Ling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pang-Hai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Xin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"5153_CR1","doi-asserted-by":"publisher","first-page":"666737","DOI":"10.3389\/fneur.2021.666737","volume":"12","author":"AN MacMahon Copas","year":"2021","unstructured":"MacMahon Copas AN, McComish SF, Fletcher JM et al (2021) The pathogenesis of parkinson\u2019s disease: a complex interplay between astrocytes, microglia, and T lymphocytes? Front Neurol 12:666737","journal-title":"Front Neurol"},{"key":"5153_CR2","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG et al (2017) Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th anniversary of the shaking palsy. Mov Disord 32:1264\u20131310","journal-title":"Mov Disord"},{"key":"5153_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386:896\u2013912","journal-title":"Lancet"},{"key":"5153_CR4","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol 15:1257\u20131272","journal-title":"Lancet Neurol"},{"key":"5153_CR5","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT (2019) Parkinson\u2019s disease and Parkinsonism. Am J Med 132:802\u2013807","journal-title":"Am J Med"},{"key":"5153_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12974-022-02605-9","volume":"19","author":"A DeMaio","year":"2022","unstructured":"DeMaio A, Mehrotra S, Sambamurti K, Husain S (2022) The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases. J Neuroinflammation 19:251","journal-title":"J Neuroinflammation"},{"key":"5153_CR7","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A et al (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119:182\u2013192","journal-title":"J Clin Invest"},{"key":"5153_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","volume":"23","author":"A Sommer","year":"2018","unstructured":"Sommer A, Marxreiter F, Krach F et al (2018) Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson\u2019s disease. Cell Stem Cell 23:123-131.e126","journal-title":"Cell Stem Cell"},{"key":"5153_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","volume":"28","author":"J Zhu","year":"2010","unstructured":"Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28:445\u2013489","journal-title":"Annu Rev Immunol"},{"key":"5153_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11481-015-9618-9","volume":"10","author":"H Gonz\u00e1lez","year":"2015","unstructured":"Gonz\u00e1lez H, Contreras F, Pacheco R (2015) Regulation of the neurodegenerative process associated to Parkinson\u2019s disease by CD4+ T-cells. J Neuroimmune Pharmacol 10:561\u2013575","journal-title":"J Neuroimmune Pharmacol"},{"key":"5153_CR11","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams GP, Schonhoff AM, Jurkuvenaite A et al (2021) CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain 144:2047\u20132059","journal-title":"Brain"},{"key":"5153_CR12","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1189\/jlb.0507296","volume":"82","author":"AD Reynolds","year":"2007","unstructured":"Reynolds AD, Banerjee R, Liu J et al (2007) Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson\u2019s disease. J Leukocyte Biol 82:1083\u20131094","journal-title":"J Leukocyte Biol"},{"key":"5153_CR13","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1007\/s00415-022-11190-z","volume":"269","author":"Y He","year":"2022","unstructured":"He Y, Peng K, Li R et al (2022) Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson\u2019s disease. J Neurol 269:5368\u20135381","journal-title":"J Neurol"},{"key":"5153_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12264-017-0163-9","volume":"33","author":"L Cen","year":"2017","unstructured":"Cen L, Yang C, Huang S et al (2017) Peripheral lymphocyte subsets as a marker of Parkinson\u2019s disease in a Chinese population. Neurosci Bull 33:493\u2013500","journal-title":"Neurosci Bull"},{"key":"5153_CR15","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F et al (2017) T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides. Nature 546:656\u2013661","journal-title":"Nature"},{"key":"5153_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir ME, Butte MJ, Freeman GJ, Sharpe AH (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677\u2013704","journal-title":"Annu Rev Immunol"},{"key":"5153_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1074-7613(04)00051-2","volume":"20","author":"X Zhang","year":"2004","unstructured":"Zhang X, Schwartz J-CD, Guo X et al (2004) Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 20:337\u2013347","journal-title":"Immunity"},{"key":"5153_CR18","doi-asserted-by":"crossref","unstructured":"Zhao J, Roberts A, Wang Z et al (2021) Emerging role of PD-1 in the central nervous system and brain diseases. Neurosci Bull  37:1188\u20131202","DOI":"10.1007\/s12264-021-00683-y"},{"key":"5153_CR19","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.1007\/s12035-021-02495-7","volume":"58","author":"Y Mi","year":"2021","unstructured":"Mi Y, Han J, Zhu J, Jin T (2021) Role of the PD-1\/PD-L1 signaling in multiple sclerosis and experimental autoimmune encephalomyelitis: recent insights and future directions. Mol Neurobiol 58:6249\u20136271","journal-title":"Mol Neurobiol"},{"key":"5153_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s42358-023-00333-z","volume":"63","author":"Z Xie","year":"2023","unstructured":"Xie Z, Dai L, He H et al (2023) The effect of PD-1\/PD-L1 signaling axis on the interaction between CD19+B cells and CD4+T cells in peripheral blood of patients with systemic lupus erythematosus. Adv Rheumatol 63:51","journal-title":"Adv Rheumatol"},{"issue":"624","key":"5153_CR21","first-page":"e611","volume":"33","author":"M Saresella","year":"2012","unstructured":"Saresella M, Calabrese E, Marventano I et al (2012) A potential role for the PD1\/PD-L1 pathway in the neuroinflammation of Alzheimer\u2019s disease. Neurobiol Aging 33(624):e611-622","journal-title":"Neurobiol Aging"},{"key":"5153_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13578-022-00897-1","volume":"12","author":"C-T Wu","year":"2022","unstructured":"Wu C-T, Chu C-I, Wang F-Y et al (2022) A change of PD-1\/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer\u2019s Disease. Cell Biosci 12:162","journal-title":"Cell Biosci"},{"key":"5153_CR23","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/ni.3867","volume":"18","author":"M Miyajima","year":"2017","unstructured":"Miyajima M, Zhang B, Sugiura Y et al (2017) Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior. Nat Immunol 18:1342\u20131352","journal-title":"Nat Immunol"},{"key":"5153_CR24","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1007\/s12035-022-02758-x","volume":"59","author":"Y-Y Cheng","year":"2022","unstructured":"Cheng Y-Y, Chen B-Y, Bian G-L et al (2022) Programmed death-1 deficiency aggravates motor dysfunction in MPTP model of Parkinson\u2019s disease by inducing microglial activation and neuroinflammation in mice. Mol Neurobiol 59:2642\u20132655","journal-title":"Mol Neurobiol"},{"key":"5153_CR25","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.2147\/JIR.S316439","volume":"14","author":"L Dong","year":"2021","unstructured":"Dong L, Zheng YM, Luo XG et al (2021) High inflammatory tendency induced by malignant stimulation through imbalance of CD28 and CTLA-4\/PD-1 contributes to dopamine neuron injury. J Inflamm Res 14:2471\u20132482","journal-title":"J Inflamm Res"},{"key":"5153_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1474-4422(12)70138-2","volume":"11","author":"U Ekman","year":"2012","unstructured":"Ekman U, Eriksson J, Forsgren L et al (2012) Functional brain activity and presynaptic dopamine uptake in patients with Parkinson\u2019s disease and mild cognitive impairment: a cross-sectional study. The Lancet Neurology 11:679\u2013687","journal-title":"The Lancet Neurology"},{"key":"5153_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12640-017-9736-7","volume":"32","author":"S Castillo","year":"2017","unstructured":"Castillo S, Mu\u00f1oz P, Behrens MI et al (2017) On the role of mining exposure in epigenetic effects in Parkinson\u2019s disease. Neurotox Res 32:172\u2013174","journal-title":"Neurotox Res"},{"key":"5153_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699","journal-title":"J Am Geriatr Soc"},{"key":"5153_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5603\/PJNNS.a2021.0071","volume":"55","author":"PW Tipton","year":"2021","unstructured":"Tipton PW, B\u00fclb\u00fcl N, Crook J et al (2021) Effects of sex and APOE on Parkinson\u2019s disease-related cognitive decline. Neurol Neurochir Pol 55:559\u2013566","journal-title":"Neurol Neurochir Pol"},{"key":"5153_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","volume":"6","author":"M Hamilton","year":"1967","unstructured":"Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278\u2013296","journal-title":"Br J Soc Clin Psychol"},{"key":"5153_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/00004583-199403000-00009","volume":"33","author":"DB Clark","year":"1994","unstructured":"Clark DB, Donovan JE (1994) Reliability and validity of the hamilton anxiety rating scale in an adolescent sample. J Am Acad Child Adolesc Psychiatry 33:354\u2013360","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"5153_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","volume":"26","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Fitzpatrick R, Peto V et al (1997) The Parkinson\u2019s disease questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score. Age Ageing 26:353\u2013357","journal-title":"Age Ageing"},{"key":"5153_CR33","doi-asserted-by":"publisher","first-page":"175628642311611","DOI":"10.1177\/17562864231161163","volume":"16","author":"R Ma","year":"2023","unstructured":"Ma R, Yin Z, Chen Y et al (2023) Sleep outcomes and related factors in Parkinson\u2019s disease after subthalamic deep brain electrode implantation: a retrospective cohort study. Ther Adv Neurol Disord 16:17562864231161164","journal-title":"Ther Adv Neurol Disord"},{"key":"5153_CR34","doi-asserted-by":"publisher","first-page":"175628642098674","DOI":"10.1177\/1756286420986744","volume":"14","author":"F Schaible","year":"2021","unstructured":"Schaible F, Maier F, Buchwitz TM et al (2021) Effects of Lee Silverman Voice Treatment BIG and conventional physiotherapy on non-motor and motor symptoms in Parkinson\u2019s disease: a randomized controlled study comparing three exercise models. Ther Adv Neurol Disord 14:1756286420986744","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"5153_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12974-021-02296-8","volume":"18","author":"D Bhatia","year":"2021","unstructured":"Bhatia D, Grozdanov V, Ruf WP et al (2021) T-cell dysregulation is associated with disease severity in Parkinson\u2019s Disease. J Neuroinflammation 18(1):250","journal-title":"J Neuroinflammation"},{"key":"5153_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L et al (2018) Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients. J Neuroinflammation 15:205","journal-title":"J Neuroinflammation"},{"key":"5153_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12974-022-02574-z","volume":"19","author":"SY Liu","year":"2022","unstructured":"Liu SY, Qiao HW, Song TB et al (2022) Brain microglia activation and peripheral adaptive immunity in Parkinson\u2019s disease: a multimodal PET study. J Neuroinflammation 19:209","journal-title":"J Neuroinflammation"},{"key":"5153_CR38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","volume":"11","author":"Y Baba","year":"2005","unstructured":"Baba Y, Kuroiwa A, Uitti RJ et al (2005) Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord 11:493\u2013498","journal-title":"Parkinsonism Relat Disord"},{"key":"5153_CR39","doi-asserted-by":"publisher","first-page":"300060521998471","DOI":"10.1177\/0300060521998471","volume":"49","author":"W Li","year":"2021","unstructured":"Li W, Luo Y, Xu H et al (2021) Imbalance between T helper 1 and regulatory T cells plays a detrimental role in experimental Parkinson\u2019s disease in mice. J Int Med Res 49:300060521998471","journal-title":"J Int Med Res"},{"key":"5153_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L et al (2018) Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4 + Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients. J Neuroinflammation 15:205","journal-title":"J Neuroinflammation"},{"key":"5153_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jneuroim.2007.05.011","volume":"188","author":"D Rosenkranz","year":"2007","unstructured":"Rosenkranz D, Weyer S, Tolosa E et al (2007) Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol 188:117\u2013127","journal-title":"J Neuroimmunol"},{"key":"5153_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12264-017-0163-9","volume":"33","author":"L Cen","year":"2017","unstructured":"Cen L, Yang C, Huang S et al (2017) Peripheral lymphocyte subsets as a marker of Parkinson\u2019s disease in a Chinese population. Neurosci Bull 33:493\u2013500","journal-title":"Neurosci Bull"},{"key":"5153_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mds.870070210","volume":"7","author":"E Fazzini","year":"1992","unstructured":"Fazzini E, Fleming J, Fahn S (1992) Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson\u2019s disease. Mov Disord 7:153\u2013158","journal-title":"Mov Disord"},{"key":"5153_CR44","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1212\/NXI.0000000000000239","volume":"3","author":"J Woulfe","year":"2016","unstructured":"Woulfe J, Gray MT, Ganesh MS, Middeldorp JM (2016) Human serum antibodies against EBV latent membrane protein 1 cross-react with \u03b1-synuclein. Neurol Neuroimmunol Neuroinflamm 3:e239","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"5153_CR45","doi-asserted-by":"publisher","first-page":"S331","DOI":"10.3233\/JPD-191729","volume":"9","author":"T Brudek","year":"2019","unstructured":"Brudek T (2019) Inflammatory Bowel Diseases and Parkinson\u2019s Disease. J Parkinsons Dis 9:S331\u2013S344","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"5153_CR46","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1172\/JCI96107","volume":"128","author":"A Petrelli","year":"2018","unstructured":"Petrelli A, Mijnheer G, Hoytema van Konijnenburg DP et al (2018) PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation. J Clin Investig 128(10):4669\u20134681","journal-title":"J Clin Investig"},{"issue":"10","key":"5153_CR47","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1093\/brain\/awac193","volume":"145","author":"D Bottigliengo","year":"2022","unstructured":"Bottigliengo D, Foco L, Seibler P et al (2022) A Mendelian randomization study investigating the causal role of inflammation on Parkinson\u2019s disease. Brain 145(10):3444\u20133453","journal-title":"Brain"},{"key":"5153_CR48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ni1443","volume":"8","author":"AH Sharpe","year":"2007","unstructured":"Sharpe AH, Wherry EJ, Ahmed R et al (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8:239\u2013245","journal-title":"Nat Immunol"},{"issue":"11","key":"5153_CR49","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nri3740","volume":"14","author":"DE Speiser","year":"2014","unstructured":"Speiser DE, Utzschneider DT, Oberle SG et al (2014) T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Nat Rev Immunol 14(11):768\u2013774","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"5153_CR50","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1084\/jem.20150598","volume":"213","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider DT et al (2016) High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survival. J Exp Med 213(9):1819\u20131834","journal-title":"J Exp Med"},{"key":"5153_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.coi.2007.04.012","volume":"19","author":"ME Keir","year":"2007","unstructured":"Keir ME, Francisco LM, Sharpe AH (2007) PD-1 and its ligands in T-cell immunity. Curr Opin Immunol 19:309\u2013314","journal-title":"Curr Opin Immunol"},{"key":"5153_CR52","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.molcel.2020.02.013","volume":"77","author":"X He","year":"2020","unstructured":"He X, Xu C (2020) PD-1: A Driver or Passenger of T Cell Exhaustion? Mol Cell 77:930\u2013931","journal-title":"Mol Cell"},{"key":"5153_CR53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.mce.2017.03.006","volume":"448","author":"A Pyzik","year":"2017","unstructured":"Pyzik A, Grywalska E, Matyjaszek-Matuszek B et al (2017) Frequencies of PD-1- positive T CD3+CD4+, T CD3+CD8+ and B CD19+ lymphocytes in female patients with Graves\u2019 disease and healthy controls- preliminary study. Mol Cell Endocrinol 448:28\u201333","journal-title":"Mol Cell Endocrinol"},{"key":"5153_CR54","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00262-011-1007-5","volume":"60","author":"TSdS Malaspina","year":"2011","unstructured":"Malaspina TSdS, Gasparoto TH, Costa MRSN et al (2011) Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma. Cancer Immunol Immunother 60:965\u2013974","journal-title":"Cancer Immunol Immunother"},{"key":"5153_CR55","doi-asserted-by":"crossref","unstructured":"Lindestam Arlehamn CS, Dhanwani R, Pham J et al (2020) \u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat Commun 11:1875","DOI":"10.1038\/s41467-020-15626-w"},{"key":"5153_CR56","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1750-2659.2011.00232.x","volume":"5","author":"S Toovey","year":"2011","unstructured":"Toovey S, Jick SS, Meier CR (2011) Parkinson\u2019s disease or Parkinson symptoms following seasonal influenza. Influenza Other Respir Viruses 5:328\u2013333","journal-title":"Influenza Other Respir Viruses"},{"key":"5153_CR57","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s40168-023-01685-w","volume":"11","author":"X-B Bai","year":"2023","unstructured":"Bai X-B, Xu S, Zhou L-J et al (2023) Oral pathogens exacerbate Parkinson\u2019s disease by promoting Th1 cell infiltration in mice. Microbiome 11:254","journal-title":"Microbiome"},{"key":"5153_CR58","doi-asserted-by":"publisher","first-page":"2278229","DOI":"10.1080\/15384047.2023.2278229","volume":"24","author":"S Huang","year":"2023","unstructured":"Huang S, Zhao Y, Lai W et al (2023) Higher PD-1\/Tim-3 expression on IFN-\u03b3+ T cells is associated with poor prognosis in patients with acute myeloid leukemia. Cancer Biol Ther 24:2278229","journal-title":"Cancer Biol Ther"},{"key":"5153_CR59","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers M, Lunceford J, Nebozhyn M et al (2017) IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest 127:2930\u20132940","journal-title":"J Clin Invest"},{"key":"5153_CR60","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fneur.2019.00232","volume":"10","author":"MT Fuzzati-Armentero","year":"2019","unstructured":"Fuzzati-Armentero MT, Cerri S, Blandini F (2019) Peripheral-central neuroimmune crosstalk in parkinson\u2019s disease: what do patients and animal models tell us? Front Neurol 10:232","journal-title":"Front Neurol"},{"key":"5153_CR61","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cytogfr.2022.07.003","volume":"67","author":"J Lu","year":"2022","unstructured":"Lu J, Wu J, Mao L et al (2022) Revisiting PD-1\/PD-L pathway in T and B cell response: beyond immunosuppression. Cytokine Growth Factor Rev 67:58\u201365","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"5153_CR62","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(24)00170-4","volume":"23","author":"A Iranzo","year":"2024","unstructured":"Iranzo A, Cochen De Cock V, Fantini ML et al (2024) Sleep and sleep disorders in people with Parkinson\u2019s disease. The Lancet Neurology 23(9):925\u2013937","journal-title":"The Lancet Neurology"},{"key":"5153_CR63","doi-asserted-by":"publisher","first-page":"107122","DOI":"10.1016\/j.rmed.2023.107122","volume":"208","author":"P Janmohammadi","year":"2023","unstructured":"Janmohammadi P, Raeisi T, Zarei M et al (2023) Adipocytokines in obstructive sleep apnea: a systematic review and meta-analysis. Respir Med 208:107122","journal-title":"Respir Med"},{"issue":"31","key":"5153_CR64","doi-asserted-by":"publisher","first-page":"12843","DOI":"10.1073\/pnas.0701466104","volume":"104","author":"G Cavadini","year":"2007","unstructured":"Cavadini G, Petrzilka S, Kohler P et al (2007) TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci USA 104(31):12843\u201312848","journal-title":"Proc Natl Acad Sci USA"},{"key":"5153_CR65","doi-asserted-by":"publisher","first-page":"115528","DOI":"10.1016\/j.psychres.2023.115528","volume":"329","author":"Y Yang","year":"2023","unstructured":"Yang Y, Gu K, Meng C et al (2023) Relationship between sleep and serum inflammatory factors in patients with major depressive disorder. Psychiatry Res 329:115528","journal-title":"Psychiatry Res"},{"key":"5153_CR66","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3390\/diagnostics13040693","volume":"13","author":"J Joo","year":"2023","unstructured":"Joo J, Jeong J, Park HJ (2023) Blood biomarkers in patients with Parkinson\u2019s Disease: a review in context of anesthetic care. Diagnostics (Basel) 13:693","journal-title":"Diagnostics (Basel)"},{"key":"5153_CR67","doi-asserted-by":"publisher","first-page":"1104393","DOI":"10.3389\/fcell.2023.1104393","volume":"11","author":"J Fu","year":"2023","unstructured":"Fu J, Chen S, Liu J et al (2023) Serum inflammatory cytokines levels and the correlation analyses in Parkinson\u2019s disease. Front Cell Dev Biol 11:1104393","journal-title":"Front Cell Dev Biol"},{"key":"5153_CR68","doi-asserted-by":"publisher","first-page":"641428","DOI":"10.3389\/fonc.2021.641428","volume":"11","author":"BL Russell","year":"2021","unstructured":"Russell BL, Sooklal SA, Malindisa ST et al (2021) The tumor microenvironment factors that promote resistance to immune checkpoint blockade therapy. Front Oncol 11:641428","journal-title":"Front Oncol"},{"issue":"7","key":"5153_CR69","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","volume":"16","author":"X Li","year":"2019","unstructured":"Li X, Wenes M, Romero P et al (2019) Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat Rev Clin Oncol 16(7):425\u2013441","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"5153_CR70","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrneurol.2017.144","volume":"13","author":"LM Yshii","year":"2017","unstructured":"Yshii LM, Hohlfeld R, Liblau RS (2017) Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives. Nat Rev Neurol 13(12):755\u2013763","journal-title":"Nat Rev Neurol"},{"key":"5153_CR71","doi-asserted-by":"publisher","first-page":"9999146","DOI":"10.1155\/2021\/9999146","volume":"2021","author":"R K\u00f6lliker-Frers","year":"2021","unstructured":"K\u00f6lliker-Frers R, Udovin L, Otero-Losada M et al (2021) Neuroinflammation: an integrating overview of reactive-neuroimmune cell interactions in health and disease. Mediators Inflamm 2021:9999146","journal-title":"Mediators Inflamm"},{"key":"5153_CR72","doi-asserted-by":"publisher","first-page":"642800","DOI":"10.3389\/fneur.2021.642800","volume":"12","author":"C Valencia-Sanchez","year":"2021","unstructured":"Valencia-Sanchez C, Zekeridou A (2021) Paraneoplastic neurological syndromes and beyond emerging with the introduction of immune checkpoint inhibitor cancer immunotherapy. Front Neurol 12:642800","journal-title":"Front Neurol"},{"issue":"2","key":"5153_CR73","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","volume":"22","author":"K Baruch","year":"2016","unstructured":"Baruch K, Deczkowska A, Rosenzweig N et al (2016) PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat Med 22(2):135\u2013137","journal-title":"Nat Med"},{"key":"5153_CR74","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F et al (2024) The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 16:1347987","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"5153_CR75","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12974-021-02308-7","volume":"18","author":"J Machhi","year":"2021","unstructured":"Machhi J, Yeapuri P, Lu Y et al (2021) CD4+ effector T cells accelerate Alzheimer\u2019s disease in mice. J Neuroinflammation 18(1):272","journal-title":"J Neuroinflammation"},{"issue":"2","key":"5153_CR76","doi-asserted-by":"publisher","first-page":"fcaa112","DOI":"10.1093\/braincomms\/fcaa112","volume":"2","author":"A Faridar","year":"2020","unstructured":"Faridar A, Thome AD, Zhao W et al (2020) Restoring regulatory T-cell dysfunction in Alzheimer\u2019s disease through ex vivo expansion. Brain Commun 2(2):fcaa112","journal-title":"Brain Commun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05153-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05153-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05153-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:02:12Z","timestamp":1757790132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05153-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5153"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05153-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our research is in accordance with ethical standards established in the Declaration of Helsinki (1964), its subsequent revisions, and the Ethical Review Measures for Biomedical Research Involving Human Subjects (2016) and the Ethical Review Measures for Life Science and Medical Research Involving Human Subjects (2023) issued by the National Health Commission of the People's Republic of China. Our project was approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University (2022.72). All of the subjects completed their approval forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}